What is NOVN.SW's gross margin?

Novartis (NOVN.SW) has a gross margin of 74% and a net margin of 23%.

What is NOVN.SW's P/E ratio?

NOVN.SW's P/E ratio is 21.3 with ROE of 30%.

Where can I see NOVN.SW's full financials?

See Novartis (NOVN.SW) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Novartis (NOVN.SW) Financials — Revenue, Earnings, Cash Flow

Also trades as: NVS (NYSE) · $vol 285M · NVSEF (OTC) · $vol 2M · NVS.TO (TSX) · $vol 0M

CHF 116.34 ($140.50)

-1.72 (-1.46%)

Weekly Expected Move ±6.1%

CHF 102 CHF 109 CHF 116 CHF 123 CHF 130

SIX · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 38 · CHF 221.1B mcap · 1.86B float · 0.156% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ETF Exposure

📊 Key Metrics

TTM

CHF 55B

Revenue

-0.7% YoY

CHF 13B

Net Income

-7.3% YoY

CHF 16B

Free Cash Flow

-11.5% YoY

74.5%

Gross Margin

32.8%

Op. Margin

22.7%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE30.3%

ROA11.2%

ROIC16.2%

Valuation

P/E21.3

P/B6.4

EV/EBITDA0.0

Leverage

Debt/Equity1.18

Current Ratio0.86

Interest Cov.12.2x

Quality Scores

Piotroski F5/9

Altman Z—

Beneish M-2.51